2024 Thematic Discussions on the Implementation of All International Drug Policy Commitments, Following-up to the 2019 Ministerial Declaration Other Substantial Matters proposed by Member States • Challenges to the identification of new illicit drugs: Discussion on strategies and approaches by laboratories to enhance the capacity of forensic personnel and harnessing technology to improve identification methods …
WHO
CND Intersessional – Session 5 – Legal, Scientific, and Regulatory Challenges in Scheduling Substances
2024 Thematic Discussions on the Implementation of All International Drug Policy Commitments, Following-up to the 2019 Ministerial Declaration Chair: Good Morning. Secretariat: (organizational matters + scheduling 101) Moderator/intro: Mr. Justice Tettey, Chief, Drugs, Laboratory and Scientific Services Branch, UNODC: Good morning, dear colleagues. Thank you for this opportunity to address the question you posed about …
CND Intersessional – Session 2 – Synthetic Opioids and Non-medical Use of Prescription Drugs
2024 Thematic Discussions on the Implementation of All International Drug Policy Commitments, Following-up to the 2019 Ministerial Declaration Chair: Welcome back. Ms. Asma Fakhri, UNODC, on behalf of Mr. Justice TETTEY, Chief, Drugs, Laboratory and Scientific Services Branch, UNODC (Moderator): Thank you all for gathering to address the growing challenges posed by synthetic opioids and the non-medical …
CND Intersessional – Session 1 – Expanding range of drugs and synthetic opioids and nonmedical use of prescription drugs
CND Intersessional meeting – Thematic discussions on the implementation of all international drug policy commitments following up to the 2019 Ministerial Declaration Secretariat: (administrative and organizational issues) Chair: Welcome. The topics of the three days of this meeting are identified in the 2019 declaration. One of the challenges is the funding and diversification of drug …
Item 5. Implementation of the international drug control treaties (Tuesday morning)
Chair: We will consider scheduling recommendations by WHO and INCB. CND Secretariat: Recalls the substances and scheduling recommendations. Chair: Explains process to schedule substances under 1961, 1971 and 1988 conventions. Butonitazene WHO: Butonitazene, or butoxynitazene, is a benzimidazole-derived synthetic opioid not currently under international control and lacking recognized therapeutic use. It appears as a crystalline …
CND Reconvened 66th Session
Chair: Good Morning. The focus of our discussion pertains to Strategic Management budgetary and administrative motions in the context of our economy. Yesterday, in collaboration with the CCP CJ, we deliberated on the Consolidated budget for the biennium 2024-2025 for the United Nations Office on Drugs and Crime, referencing Containers document 5.2 (2013) and 15/2017, …